LeMaitre Vascular, Inc.
LMAT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.06 | 0.94 | -1.89 | 1.89 |
| FCF Yield | 1.80% | 2.34% | 2.19% | 2.84% |
| EV / EBITDA | 33.39 | 25.64 | 27.32 | 23.16 |
| Quality | ||||
| ROIC | 7.72% | 8.77% | 7.02% | 10.48% |
| Gross Margin | 68.63% | 65.66% | 64.89% | 65.65% |
| Cash Conversion Ratio | 1.00 | 1.22 | 1.23 | 1.30 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.80% | 7.81% | 7.71% | 9.62% |
| Free Cash Flow Growth | 26.03% | 33.13% | -26.71% | -5.02% |
| Safety | ||||
| Net Debt / EBITDA | 2.40 | -0.11 | -0.07 | 0.05 |
| Interest Coverage | 254.91 | 0.00 | 0.00 | 16.42 |
| Efficiency | ||||
| Inventory Turnover | 1.23 | 1.27 | 1.25 | 1.30 |
| Cash Conversion Cycle | 336.68 | 314.29 | 322.29 | 310.00 |